Allarity Therapeutics, Inc. (ALLR) - Latest Market Data

Price & Market Data

Price: $1.75

Daily Change: +$0.09 / 5.14%

Daily Range: $1.58 - $1.78

Market Cap: $28,161,982

Daily Volume: 316,476

Performance Metrics

1 Week: 6.67%

1 Month: 11.89%

3 Months: 52.38%

6 Months: 60.00%

1 Year: 50.94%

YTD: 45.45%

About Allarity Therapeutics, Inc. (ALLR)

A detailed overview of Allarity Therapeutics, Inc. (ALLR) reveals a price of 1.75 and a daily shift of +$0.09 / 5.14%. The market cap is currently 28,161,982. Comprehensive performance figures for 1-week (6.67%) and 3-month (52.38%) periods are available.

Company Details

Employees: 8

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Allarity Therapeutics, Inc., a clinical-stage precision medicine pharmaceutical company, focuses on developing anti-cancer therapeutics for patients with unmet medical needs in Denmark and the United States. The company develops drugs for the personalized treatment of cancer using drug-specific companion diagnostics generated by its proprietary drug response predictor (DRP) technology. Its lead drug candidate is stenoparib, a dual inhibitor of poly-ADP-ribose polymerase (PARP1/2), which is in a Phase 2 clinical trial for patients with advanced and recurrent ovarian cancer. It is also developing stenoparib with temozolomide, a PARP and WNT inhibitor in combination with a DNA-alkylating chemotherapy agent, which is in a Phase 2 clinical trial for patients with relapsed small cell lung cancer; and stenoparib-DRP, a companion diagnostic product used to select patients for stenoparib treatment. Allarity Therapeutics, Inc. is headquartered in Tarpon Springs, Florida.

Selected stocks

Radiopharm Theranostics Limited (RADX)

Dogness (International) Corporation (DOGZ)

Grande Group Limited (GRAN)

Ceragon Networks Ltd. (CRNT)

EVgo Inc. (EVGO)